[HTML][HTML] Non-coding RNAs modulating estrogen signaling and response to endocrine therapy in breast cancer
O Treeck, S Haerteis, O Ortmann - Cancers, 2023 - mdpi.com
Simple Summary Endocrine therapy is a common treatment for estrogen-responsive breast
cancer, which is used to block the tumor growth-promoting effect of this hormone. The …
cancer, which is used to block the tumor growth-promoting effect of this hormone. The …
Selective Estrogen Receptor Modulators (SERMs) for the treatment of ER+ breast cancer: An overview
S Das, S Kulkarni, Y Singh, P Kumar… - Journal of Molecular …, 2022 - Elsevier
Breast cancer is a major threat to women's lives throughout the world. Hormone-dependent
or estrogen-receptor positive (ER+) breast cancer accounts for more than 80% of all …
or estrogen-receptor positive (ER+) breast cancer accounts for more than 80% of all …
[HTML][HTML] Breast cancer MCF-7 cell spheroid culture for drug discovery and development
G Chen, W Liu, B Yan - Journal of cancer therapy, 2022 - ncbi.nlm.nih.gov
In vitro 3D cancer spheroids (tumoroids) exhibit a drug resistance profile similar to that found
in solid tumors. 3D spheroid culture methods recreate more physiologically relevant …
in solid tumors. 3D spheroid culture methods recreate more physiologically relevant …
Rational design, synthesis, antiproliferative activity against MCF-7, MDA-MB-231 cells, estrogen receptors binding affinity, and computational study of …
Based on the structural architecture of estrogen receptors (ER) agonists/antagonists, we
rationally designed and synthesized indenopyrimidine-2, 5-dione analogs as a starting point …
rationally designed and synthesized indenopyrimidine-2, 5-dione analogs as a starting point …
A comprehensive review on Thiazole based Conjugates as Anti-cancer Agents
Over the past few decades, a significant number of anticancer drugs have been developed,
both natural and synthetic. Thiazole, a 5-membered distinctive heterocyclic motif with …
both natural and synthetic. Thiazole, a 5-membered distinctive heterocyclic motif with …
Hybridization of molecular docking studies with machine learning based QSAR model for prediction of xanthine oxidase activity
Xanthine Oxidase inhibitors treat hyperuricemia, but associated side effects have led
researchers to discover new inhibitors with fewer side effects. Our study employed a hybrid …
researchers to discover new inhibitors with fewer side effects. Our study employed a hybrid …
Sulfonamides as anticancer agents: A brief review on sulfonamide derivatives as inhibitors of various proteins overexpressed in cancer
Sulfonamides have gained prominence as versatile agents in cancer therapy, effectively
targeting a spectrum of cancer-associated enzymes. This review provides an extensive …
targeting a spectrum of cancer-associated enzymes. This review provides an extensive …
Pathology, target discovery, and the evolution of XO inhibitors from the first discovery to recent advances (2020–2023)
Hyperuricemia, a disease characterized by elevation of serum uric acid level beyond 6
mg/dL. This elevation led to appearance of symptoms from joint pain to gout and from gout to …
mg/dL. This elevation led to appearance of symptoms from joint pain to gout and from gout to …
Synthesis, in silico and investigation of anti-breast cancer activity of new diphenyl urea derivatives: Experimental and computational study
Cancer is a complex disease that requires multidisciplinary treatment. One of the most
common cancers is breast cancer, and these cancers are usually estrogen receptor-positive …
common cancers is breast cancer, and these cancers are usually estrogen receptor-positive …
[HTML][HTML] Cyclopia extracts act as selective estrogen receptor subtype downregulators in estrogen receptor positive breast cancer cell lines: Comparison to standard of …
FR Olayoku, NJD Verhoog, A Louw - Frontiers in Pharmacology, 2023 - frontiersin.org
Breast cancer is the most diagnosed type of cancer amongst women in economically
developing countries and globally. Most breast cancers express estrogen receptor alpha …
developing countries and globally. Most breast cancers express estrogen receptor alpha …